KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) Shares Outstanding (Weighted Average) (2016 - 2026)

Ionis Pharmaceuticals (IONS) has disclosed Shares Outstanding (Weighted Average) for 18 consecutive years, with $164.9 million as the latest value for Q1 2026.

  • For Q1 2026, Shares Outstanding (Weighted Average) rose 3.87% year-over-year to $164.9 million; the TTM value through Mar 2026 reached $164.9 million, up 3.87%, while the annual FY2025 figure was $160.0 million, 7.02% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $164.9 million in Q1 2026 for Ionis Pharmaceuticals, up from $160.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $164.9 million in Q1 2026 and bottomed at $141.6 million in Q1 2022.
  • Average Shares Outstanding (Weighted Average) over 5 years is $148.9 million, with a median of $145.5 million recorded in 2024.
  • Year-over-year, Shares Outstanding (Weighted Average) grew 0.58% in 2022 and then rose 9.19% in 2025.
  • Ionis Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $141.8 million in 2022, then increased by 0.95% to $143.2 million in 2023, then rose by 4.42% to $149.5 million in 2024, then rose by 7.02% to $160.0 million in 2025, then increased by 3.04% to $164.9 million in 2026.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $164.9 million, $160.0 million, and $159.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.